I'm a member
You will be redirected to myBlue. Would you like to continue?
Please wait while you are redirected.
Please enter a username and password.
Printer Friendly Version
Adequate sedation and analgesia are important parts of diagnostic and therapeutic endoscopic procedures. Various levels of sedation and analgesia (anesthesia) may be used depending on the patient’s status and the procedure being performed.
Monitored anesthesia care (MAC) is directly provided by anesthesia personnel. MAC may include varying levels of sedation, analgesia, and anxiolysis. (If the patient loses consciousness and the ability to respond purposefully, the anesthesia care becomes general anesthesia.) Based on the American Society of Anesthesiologists’ (ASA) standard for monitoring, MAC should be provided by qualified anesthesia personnel who must be present continuously to monitor the patient and provide anesthesia care. Monitored anesthesia care includes all aspects of anesthesia care – a pre-procedure visit, intra-procedure care and post-procedure anesthesia management. During MAC, the anesthesiology personnel provides or medically directs a number of specific services such as administration of sedatives, analgesics, hypnotics, anesthetic agents or other medications as necessary.
Propofol is an agent that has been used increasingly to provide monitored anesthesia care for endoscopic procedures. Propofol is associated with a rapid onset of action and fast recovery from sedation. However, there have been concerns about potential side effects and safety when used by non-anesthesiologists. It has the potential to induce general anesthesia, and there is no pharmacologic antagonist to reverse its action. In many practice situations, it is common for propofol to be administered by anesthesiologists, whereas moderate sedation using diazepines with or without narcotics is usually administered by or under the supervision of the endoscopist.
Propofol (marketed as Diprivan® or as generic products) was first approved by the U.S. Food and Drug Administration in the late 1980s. The current FDA-approved label for Diprivan states that it is indicated for initiation and maintenance of Monitored Anesthesia Care (MAC) sedation, combined sedation and regional anesthesia, or Intensive Care Unit (ICU) sedation of intubated, mechanically ventilated patients in adults only. It is also approved for induction of general anesthesia in patients greater than or equal to 3 years of age, and maintenance of general anesthesia in patients greater than or equal to 2 months of age.
This policy only addresses anesthesia services for diagnostic or therapeutic endoscopic procedures.
POLICYUse of monitored anesthesia care may be considered medically necessary for gastrointestinal endoscopic procedures when there is documentation by the endoscopist and anesthesiolgist that specific risk factors or significant medical conditions are present. Those risk factors or significant medical conditions are as follows:
Use of monitored anesthesia care is considered not medically necessary for gastrointestinal endoscopic procedures in patients at average risk related to use of anesthesia and sedation who are undergoing gastrointestinal endoscopic procedures, including endoscopic procedures used in screening.
Other indications for Colonoscopy, Flexible Sigmoidoscopy, and CT Colonography, are discussed in a separate policy.
*American Society of Anesthesiologists classification system for assessing a patient before surgery:
The coverage guidelines outlined in the Medical Policy Manual should not be used in lieu of the Member’s specific benefit plan language.
POLICY HISTORY5/26/2009: Policy added
7/06/2009: Link to Colonoscopy, Flexible Sigmoidoscopy, and CT Colonography added to Policy Statement
04/21/2010: Policy statement revised to change “Patients age 70 or greater” to “Patients of extreme age.” Reworded statement regarding patients at average risk.
08/11/2010: Policy reviewed; no changes.
04/18/2011: Policy statement updated to add examples of patients with increased risk for airway obstruction. Also added the following risk factors: morbid obesity, severe sleep apnea, inability to follow simple commands, spasticity or movement disorder complicating procedure, or history or anticipated intolerance to standard sedatives. Added the American Society of Anesthesiologists (ASA) physical status classifications to the Policy Guidelines.
06/21/2011: Added the risk factor "Patients of extreme age, i.e., younger than age 12 or age 70 years or older" back to the policy statement.
02/24/2012: Policy statement revised to change the BMI for morbid obesity from > 50 to >40.
05/09/2012: Policy reviewed; no changes.
07/18/2013: Policy statement revised to change severe sleep apnea (oxygen and bi-pap required during sleep) to documented sleep apnea; history of sleep apnea was removed from the patients with increased risk for airway obstruction due to anatomic variation criteria; and patients of extreme age, i.e., younger than age 12 or age 70 years or older was changed to patients younger than 18 years or 70 years or older.
03/19/2014: Policy reviewed; no changes.
08/31/2015: Code Reference section updated for ICD-10.
SOURCESBlue Cross & Blue Shield Association policy # 7.02.01
This may not be a comprehensive list of procedure codes applicable to this policy.
The code(s) listed below are ONLY medically necessary if the procedure is performed according to the "Policy" section of this document.